show episodes
 
Artwork

1
Evaluating Biopharma

Evaluating Biopharma

Unsubscribe
Unsubscribe
Monthly
 
Evaluating Biopharma taps into the insight and experience of biopharmaceutical leaders so today’s decision makers can leverage their knowledge, learn from their successes, and avoid repeating similar mistakes. This series offers a new guest and moderator with each episode and aims to equip executives and science leaders with the necessary information to make better business and process decisions. The Evaluating Biopharma podcast is a reproduction of content originally presented at recent Eva ...
  continue reading
 
The Business of Biotech is the pod dedicated to leaders of emerging biopharma firms. SUBSCRIBE to our new newsletter at www.bioprocessonline.com/bob. We bring you insight into organizational, finance and funding, HR, clinical, manufacturing, and regulatory challenges you’ll face as you navigate your company from an idea to success in the clinic. Each episode features guest commentary and best practices from accomplished founders and biopharma industry luminaries. The Business of Biotech is p ...
  continue reading
 
Artwork

1
BioBoss

John Simboli

Unsubscribe
Unsubscribe
Monthly
 
BioBoss is a podcast about leadership in the biopharma community. Hear directly from the founders and CEOs of today's most innovative companies. Listen in as Wyant Simboli Principal and branding veteran John Simboli poses the questions "What drives you? How do you create change? Why should people care?" to biopharma leaders and hear insights on this rapidly developing field.
  continue reading
 
Perspectives from the cutting edge of biotech and pharma. The fast-changing world of biopharma places a premium on trusted market insights from industry experts who can turn change into a competitive advantage. Stay ahead of the curve with our latest podcast series. Lead today. Define tomorrow.
  continue reading
 
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
  continue reading
 
The Syneos Health Podcast Series dissects some of the most complex issues biopharma leaders are facing today. Our clinical and commercial experts provide time-tested solutions, as well as perspectives on the news of the day. Hosted by Jeff Stewart, a long-time industry consultant who has advised biopharma leaders on licensing, mergers and acquisitions, pricing and market access, commercialization and go-to-market strategies, each episode explores the challenges and considerations involved wi ...
  continue reading
 
Artwork

1
Biopharma EHS

Affygility Solutions, LLC

Unsubscribe
Unsubscribe
Monthly
 
BioPharma EH&S Podcast. The latest discussion on potent compound safety, occupational toxicology, industrial hygiene, and compliance management software. To submit questions or comments to the podcast email affygility@gmail.com or call our listener voicemail line at 206-984-3214.
  continue reading
 
For biopharma pros seeking insightful discussions and a deeper understanding of the pharma world, join Dr. Na-Ri Oh and Ian Wendt as they talk with industry leaders and luminaries to delve into biotechnology, pharmaceuticals, and healthcare. RealPharma podcast aims to challenge your viewpoints, deepen your understanding of the pharma world beyond the headlines, and explore emerging trends in medical innovation.
  continue reading
 
Artwork

1
Back Bay Life Science Report

Jonathan P. Gertler and Peter Bak

Unsubscribe
Unsubscribe
Monthly
 
Back Bay Life Science Advisors brings you expert insights from our advisors and investment bankers in the world of BioPharma & MedTech. On this podcast, you’ll hear from our experts in life science development, commercialization, and investment banking, scientific investigators, biotech and medtech executives, physicians, and strategists who excel at guiding global life sciences companies and their investors through complex decisions. Join us for insights generated from in-depth scientific, ...
  continue reading
 
Artwork

1
The Top Line

Fierce Life Sciences

Unsubscribe
Unsubscribe
Weekly
 
Biopharma and medtech explained. Every week, journalists from Fierce Biotech, Fierce Medtech, and Fierce Pharma recount the latest industry trends and why they matter. We'll analyze the week's biggest business news, from mergers and marketing to drug R&D and device development. Available every Friday morning.
  continue reading
 
Tune in to BioCentury’s in-depth conversations with global leaders who are advancing the future of medicine. Join our Senior Editors in face-to-face discussions with scientific KOLs, top executives, VCs, and key policymakers, dissecting the most urgent public health issues. The BioCentury Show is THE only place where BioCentury’s experts join top innovators and global influencers to show how science is being turned into medicine. Don't miss this event, every two weeks, now available as a vid ...
  continue reading
 
Artwork

1
Vital Health Podcast

Vital Health Podcast

Unsubscribe
Unsubscribe
Monthly
 
Duane Schulthess is the CEO of Vital Transformation, host and producer of Vital Health Podcast. Vital Transformation understands the implications of new medical procedures, technologies and regulations. We measure their impact upon treatment pathways and the biopharma innovation ecosystem in collaboration with health care professionals, researchers, and regulators. Through our web platform and client network, we are able to communicate our findings with international decision makers and stak ...
  continue reading
 
Artwork
 
Here at Drug Discovery World (DDW) we've been publishing articles written by leading experts in the Drug Discovery, Pharmaceutical, and BioPharmaceutical industries for over 20 years. DDW has grown as a quarterly business review of drug discovery and development, and now we've created this podcast to allow you to listen to our articles on the go. In our journal and this podcast, we cover topics surrounding: drug discovery; drug development; business; chemistry; enabling technologies; informa ...
  continue reading
 
AI For Pharma Growth is the podcast from pioneering Artificial Intelligence entrepreneur Dr. Andree Bates created to help Pharma, Biotech and other Healthcare companies understand how the use of AI-based technologies can easily save them time and grow their brands and company results. This show blends deep experience in the sector with demystifying AI for biopharma execs from biotech start-ups right through to big pharma. In this podcast, Dr Andree will teach you the tried and true secrets t ...
  continue reading
 
Join Nancy Donohoo’s bi-weekly podcast, Talk at the Top, and get to know the key influencers in life sciences and healthcare who are positively impacting patients, providers, consumers and the industry itself! Nancy’s guests include groundbreakers and executives from across the healthcare spectrum: CEOs, physician executives, medical affairs and scientific leaders, venture capital and private equity investors, academics and entrepreneurs. This is your front row ticket to discussions on innov ...
  continue reading
 
Contract Pharma is the premier media outlet linking contract service providers and their pharma/biopharma sponsors. Rooted in our legacy print publication—issued 9 times per year—the Contract Pharma brand continues to evolve across its digital media platforms through ContractPharma.com, Contract Pharma Direct eNewsletters, and social media channels.
  continue reading
 
Artwork
 
Kurt Wehrle is a Chicago-based enterprising worldwide business pioneer with 20+ long periods of assorted and progressive P&L management in top-notch Biopharma, Medical Device, and Diagnostic organizations. Kurt Wehrle has a demonstrated history of creating multi-layered worldwide systems, building frameworks, changing business, extending topographies, and creating on the web capacities to essentially expand income and EBITDA.
  continue reading
 
The Life Sciences D’n’A podcast is hosted by Dr. Amar Drawid, an industry veteran and AI expert who has worked in data science leadership with top biopharmaceutical companies. He explores the evolving use of AI and data science with innovators working to reshape all aspects of the biopharmaceutical industry from the way new therapeutics are discovered to how they are marketed.
  continue reading
 
Your Brain On... is a podcast by Learning and Development professionals for Learning and Development professionals. Every day, Salience Learning combines the science of learning with expertise in the business of science to help solve the biopharma industry's most complex business challenges. Listen as hosts Karen Foster and Krista Gerhard discuss the latest in cognitive science and learning strategies as they relate to the ever-evolving healthcare industry. In other words: Your Brain On... g ...
  continue reading
 
Whether you’re a CEO, developer, non-technical co-founder, designer, or you just have an idea... Philly Tech Entrepreneurs is a group meant to bring together the tech startup community of Philadelphia. Our mission is to strengthen and expand the Philadelphia Entrepreneurial scene by hosting monthly meetups and workshops featuring experts in tech-related fields such as business growth, digital marketing, SEO, design, development, and more!
  continue reading
 
Artwork
 
Welcome to "Visionary Voices," the podcast where we dive into the minds of business owners, founders, executives, and everyone in between. Each episode brings you face-to-face with the leading lights of industry and innovation. Join us as we uncover the stories behind the success and the lessons learned along the way. Whether you're climbing the corporate ladder or just starting your business journey, these are the conversations you need to hear - packed with visionary voices and insights. L ...
  continue reading
 
LARVOL & Friends is a must-listen for anyone interested in hearing about insights and exclusive takes from industry experts and business leaders about the evolution, intersection and future of biopharma, technology, business, and competitive intelligence! Since 2004, LARVOL has been accelerating decision-making by providing real-time, customized intelligence and software solutions with data-driven analytics to the most prominent pharmaceutical, biotech, and healthcare companies in the world. ...
  continue reading
 
Artwork

1
Rare Insights: Uncovering The Future Of Rare Disease Treatments

Know Rare (Taren Grom, Liz Kay, Kaitlyn Taylor, Nina Wachsman, and DNA Today’s Kira Dineen)

Unsubscribe
Unsubscribe
Monthly
 
On “Rare Insights” we bridge the gap between those living with rare diseases and the biopharmaceutical industry. Know Rare amplifies the voices of individuals with rare conditions, providing invaluable perspectives to accelerate therapeutic solutions. Join us as we dive deep into the complexities of rare diseases, exploring real-world insights from passionate industry leaders. Together, we navigate the unknowns and unlock the potential for groundbreaking treatments. Because in this journey, ...
  continue reading
 
Artwork

1
Lean By Design

Oscar Gonzalez & Lawrence Wong

Unsubscribe
Unsubscribe
Monthly
 
Lean by Design delves into the dynamic world of biotech, pharma, and life sciences, focusing on operational excellence through effective workflow and process optimization. Join hosts Oscar Gonzalez and Lawrence Wong as they engage with industry leaders who share their insights, innovative strategies, and real-world experiences in transforming complex challenges into streamlined, efficient solutions. Through thought-provoking conversations, you’ll gain practical tips and inspiration to drive ...
  continue reading
 
Welcome to our podcast where we dive into the dynamic world of pharmaceutical careers with a sprinkle of fun and a dash of humor! With nearly a decade of experience in medical affairs, a bioscience master’s degree, and a background in medcomms, I'm here to make your journey into pharma exciting and accessible. Whether you’re thinking about a career change, making the leap from an agency to pharma, or coming from a clinical background or bioscience education, this podcast is for you. From my ...
  continue reading
 
Artwork

1
HedgeD

Morgan Creek Capital Management, LLC

Unsubscribe
Unsubscribe
Monthly
 
HedgeD, with a capital “D” for emphasis, brings listeners topical content from both sides of the ledger – the long side and the short side. In each episode, co-hosts Mark Yusko, Cory Lester and Andrew Schmeelk take a deep dive into an investment theme or concept, typically with the help of an expert guest from Morgan Creek’s expansive global network.
  continue reading
 
Every medicine in your pharmacy has a human story behind it. Real people doing real work and living real lives. We all have romantic ideas about scientists working late into the evening or doctors dropping everything to answer a phone call about a patient. You can almost envision the moment when one of those researchers finally solves an intellectual puzzle and leaps into action. Their eyes go from an empty stare to an alert laser-like focus. They sit a bit taller and start to read frantical ...
  continue reading
 
The TechCrunch Live Podcast helps founders build better venture backed businesses. Each week, we chat with experienced entrepreneurs and investors on their past wins and losses — particularly the pitches that helped build the business at an early stage.
  continue reading
 
Artwork

1
The Longevity Biotech Show

The Longevity Biotech Show

Unsubscribe
Unsubscribe
Monthly
 
A weekly live audience show featuring the people building and funding companies that are extending healthy human lifespan. Join us Thursdays on Clubhouse and check the show schedule on longevitybiotechshow.com Hosted by Nathan Cheng (founder @ Longevity Marketcap // Longevity List) and Robert Ziman (Cohen Lab).
  continue reading
 
Artwork

1
AI Uncovered

Timothy Martin, Executive VP of Product at Yseop

Unsubscribe
Unsubscribe
Monthly
 
Welcome to AI Uncovered, a podcast for technology enthusiasts that explores the intersection of generative AI, machine learning, and innovation across regulated industries. With the AI software market projected to reach $14 trillion by 2030, each episode features compelling conversations with an innovator exploring the impact of generative AI, LLMs, and other rapidly evolving technologies across their organization. Hosted by Executive VP of Product at Yseop, Tim Martin leads a global team an ...
  continue reading
 
Join us as we swap ideas with thinkers, innovators and doers from around the world and around L.E.K. Presented by consulting powerhouse L.E.K. Consulting (www.lek.com), Insight Exchange™ is a new forum dedicated to the free and open exchange of the most interesting, important, and urgent ideas in the world of business. From the farthest-reaching environmental issues to innovations in retail, industrials, and healthcare, every installment of Insight Exchange™ invites luminaries to tell us wha ...
  continue reading
 
Loading …
show series
 
Summary In this conversation, Oscar Gonzalez shares his journey as a process consultant in the biopharma and biotech industries. He discusses the importance of optimizing internal operations, understanding clinical processes, and setting clear expectations with clients. Oscar emphasizes the need for effective communication and strategy in managing …
  continue reading
 
With over 40 years of experience, Bill Monteith is a veteran in pharmaceutical and biotech manufacturing. He recently joined Kymanox, and today he shares his insight with Business Development Manager Chris Adkins. They discuss some of the industry's biggest challenges, from scaling up manufacturing for biologics to navigating complex quality and op…
  continue reading
 
The increasing demand for AI talent in the life sciences industry is presenting a challenge for biopharma HR departments. Companies must compete for skilled workers not only against their competitors but also against tech firms that often offer more attractive compensation packages. Steve Swan, CEO of the Swan Group, sat down with Amar Drawid to di…
  continue reading
 
Scrip senior writer Joseph Haas discusses recent merger-and-acquisition activity in the biopharma sector with Gerardo Ubaghs, CFO of Frontier Medicines, and Jason Silvers, CFO of Generate Biomedicines. The panel looks at why M&A activity metrics declined during both the second and third quarters despite a strong start to the year and apparent posit…
  continue reading
 
In this episode of Evaluating Biopharma, host Ben Locwin and Scott Endicott, executive leader of Healthcare Solutions Integration, talk about data governance and data provenance—why they matter and how the industry can achieve them. With 30 years of experience, Endicott has a deep understanding of training AI and ML models, particularly when patien…
  continue reading
 
Just like the life sciences industry, the Driving Digital in Biopharma series has evolved. In each episode, we'll explore the way the industry is being reimagined and reinvented. If you're passionate about the future of medicines and medical technologies, improving patient outcomes and pushing the limits of innovation, The Lens is your essential li…
  continue reading
 
In this insightful episode of the Vital Health Podcast, we dive deep into the economic and societal benefits of investing in healthcare. Our esteemed guests, Professor Herwig Ostermann, Executive Director, Austrian National Public Health Institute, Professor Dennis A. Ostwald, CEO, WifOR Institute and Professor at Steinbeis School of International …
  continue reading
 
In this episode of AI for Pharma Growth, Dr. Andree Bates hosts Dr. Louis Rosenberg, founder and CEO of Unanimous AI, to discuss the revolutionary impact of swarm intelligence on group decision-making and forecasting in the pharmaceutical industry and beyond. Dr. Rosenberg explains how Unanimous AI's platforms—Swarm and ThinkScape—enhance the colle…
  continue reading
 
Send us a text In this episode of Lean by Design, we’re joined by Lisa Bodell, CEO of FutureThink, to unpack a counterintuitive truth: complexity is innovation’s worst enemy. From her days in advertising to her role as a simplicity guru in biopharma, Lisa shares a journey fueled by one mission—cutting through the noise to make work... actually work…
  continue reading
 
The latest episode of the DDW Highlights podcast is now available to listen to. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With the Society for Immunotherapy of Cancer (SITC) 2024 taking place in Houston recently, there have been a number of recent announcements regard…
  continue reading
 
In this conversation, Aaron Burnett, from Wheelhouse DMG, discusses the rapid evolution of digital marketing in the healthcare sector, emphasizing the importance of data strategy and compliance with regulations like HIPAA. He highlights the shift from third-party data reliance to first-party data utilization, which enhances marketing effectiveness …
  continue reading
 
We love to hear from our listeners. Send us a message. In August of this year, the first TCR cell therapy to be approved for use in the U.S. was greenlighted by the FDA for patients with resectable or metastatic synovial sarcoma who have previously received chemotherapy. It marked the first new treatment for those patients in more than a decade; a …
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 15 November 2024. In this episode: muscling into the obesity market; AbbVie’s schizophrenia failure; Bayer will not take risky bets; generally strong Q2 for Japanese majors; and AstraZeneca juggles China and growth questions. https://insights.citeline.com/s…
  continue reading
 
 Last month, the NIH announced that it had found evidence of research misconduct by Eliezer Masliah, M.D., the head of the neuroscience division at the National Institute on Aging. The NIH announcement coincided with the Sept. 26 publication of an investigation by Science, finding that 132 papers published by Masliah appear to contain manipulated i…
  continue reading
 
Pink Sheet reporter and editors, and guest Michael McCaughan of Prevision Policy, continue the discussion of Donald Trump’s potential impact on the FDA, including how Robert F. Kennedy Jr. could change the agency as head of HHS (:37), whether lasting changes are coming to the FDA (13:00), and Commissioner Robert Califf’s request that industry help …
  continue reading
 
With new governments both side of the pond, capital markets picking up, and some geopolitical overhang, there’s a mixed feast for biotech, with a net trend to the positive, says Sidley Austin’s Robert Darwin, who specializes in global M&A and private equity for life sciences and healthcare companies and investors. In conversation with Editor in Chi…
  continue reading
 
Summary In this conversation, Pankaj Singh, an emotional intelligence expert, shares his journey and insights on the importance of mindfulness in decision-making and leadership. He discusses how his experiences, including a ransomware attack during COVID, led him to reflect on the role of emotional awareness in navigating challenges. Pankaj emphasi…
  continue reading
 
In this episode, we explore the intersection of artificial intelligence (AI) and healthcare supply chains with Philip Ashton, founder and CEO of 7bridges. As healthcare systems globalise, the pharmaceutical supply chain becomes increasingly complex and vulnerable to disruptions. Ashton reveals how AI and real-world data are revolutionising supply c…
  continue reading
 
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. This week DDW has reported on significant investment in the development of treatments for neurodegenerative diseases, but also gene therapie…
  continue reading
 
We love to hear from our listeners. Send us a message. On this episode of the Business of Biotech, Bill and Melinda Gates Medical Research Institute's (Gates MRI) Dr. Claire Wagner joins us to share insights into her work as head of Corporate Strategy and Market Access there. She shares the development of her North Star while working with the incom…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 8 November 2024. In this episode: what Trump might mean for pharma; Novo’s semaglutide hits mark in NASH; AstraZeneca leads the way in clinical trials; Viking’s weight loss data excite; and how to speed up MLR reviews. https://insights.citeline.com/scrip/qu…
  continue reading
 
In the latest episode of the In Vivo podcast, Noam Solomon, co-founder and CEO of Israeli-American biotech Immunai explains how his company is mapping the immune system and using AI to predict individual immune responses to drugs. Noam also discusses the company's own acquisitions, partnerships, the differences between innovation and invention, art…
  continue reading
 
Contract development and manufacturing organizations (CDMOs) are reshaping pharmaceutical production, playing a pivotal role in supply chain stability and driving innovation. In today’s fast-evolving environment, CDMOs help life sciences companies enhance speed, flexibility, and efficiency, which ultimately advances access to life-saving therapies.…
  continue reading
 
Each year, we dive into the world of biotech closures and layoffs, tracking the industry’s pulse as companies navigate high risks and harsh realities. In this week's episode of "The Top Line," Fierce editors Gabrielle Masson and Andrea Park take a closer look at this year’s biotech graveyard, which tracks biotechs that have shuttered or are in the …
  continue reading
 
The topic of bispecific antibodies has been an area of interest in the pharma space for a long time now. The recent news of the notable late-stage data from Akeso and Summit’s PD-1/VEGF bispecific antibody ivonescimab to treat non-small cell lung cancer that has captured the industry writ large encouraged us to revisit the topic. To date, there hav…
  continue reading
 
Pink Sheet reporter and editors discuss potential changes that the incoming Trump Administration could make on the FDA, as well as worries about political interference in decision-making, and policy and staffing changes.More On These Topics From The Pink SheetUS FDA’s Drug Approval Norms Could Be Upended In Second Trump Term: https://insights.citel…
  continue reading
 
Whitney Akinola shares her journey from a career in software engineering to founding Future Proof, a consulting firm focused on helping businesses adapt through automation and tech integration. Discussing the challenges and excitement of entrepreneurship, she emphasizes the importance of embracing technology to future-proof small businesses. 📌 Time…
  continue reading
 
In this week’s Digital Health Roundup, Medtech Insight’s Marion Webb talks about her interview with GE HealthCare’s chief AI officer Parminder Bhatia at HTLH on his vision for AI in health care. Natasha Barrow discusses her interview with Owkin on the EU AI Act and highlights Click Therapeutics’ latest clinical results.…
  continue reading
 
Join us at the Gastein Health Conference for an insightful conversation on Europe's healthcare challenges and innovations! Host Duane Schulthess sits down with experts like Josep Figueras, the Founder and Director of the European Observatory on Health Systems and Policy, Francesca Colombo, the Head of the OECD Health Division, and Annemiek Verkamma…
  continue reading
 
In this episode, Dr Andree Bates sits down with Dr Jayne Morgan, Vice President of Medical Affairs and On-Air Medical Expert. They discuss the transformative role of artificial intelligence (AI) in patient care, telehealth, and the future of diagnostics. Dr Morgan provides an insider’s perspective on the challenges and ethical concerns facing AI-dr…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 1 November 2024. In this episode: Lilly plans DTC tirzepatide ads; Pfizer’s Bourla defends strategy; expert views from BioFuture; China retains attractions for some; and AbbVie’s Aliada acquisition.Playlist: soundcloud.com/citelinesounds/sets/scrips-five-mu…
  continue reading
 
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week that saw a second monoclonal antibody rejected by UK regulator NICE, antibodies have been high on the news agenda. More positively…
  continue reading
 
In this latest episode of RealPharma, we’re diving back into the fascinating world of AI in pharma, breaking down all the insights from our conversation with the brilliant Andree Bates! If you missed it or want to catch the highlights, this episode serves up a concise, punchy summary covering everything from predictive analytics to patient outcomes…
  continue reading
 
We love to hear from our listeners. Send us a message. Becoming a biotech CEO wasn't on Paul Romness' bingo card. He'd forged his place in the biopharma industry as a foremost public and policy affairs expert. Thirteen years at J&J, more than 5 at Amgen, and half a dozen at Boehringer Ingelheim had earned him the right to coast into a consulting gi…
  continue reading
 
As the 2024 U.S. presidential election nears, the choice between Democratic nominee Vice President Kamala Harris and Republican nominee former President Donald Trump will shape the future of drug pricing policy. While both candidates have pledged to reduce drug costs, their approaches are likely to differ significantly. In this week's episode of "T…
  continue reading
 
Richard Pazdur, director of FDA’s Oncology Center of Excellence, joined FDA in 1999. Looking back on his 25th anniversary, he draws a line between unpopular decisions at the start of his tenure and a surge in cancer drug development over the last 20 years. He believes this and other lessons from the regulation of oncology can be applied broadly acr…
  continue reading
 
This is the latest episode of the free DDW narrated podcast, titled "How to streamline regulatory approval", which covers two articles written for Volume 24 – Issue 1, Winter 2022/2023 of DDW. They are called: Quicker time to regulatory submission through improved data management and The three key stages to a successful specialty drug launch. In th…
  continue reading
 
🎧 Welcome to Episode 52 of the Philly Tech Connect Podcast! This week, we’re excited to host Bill Evans, a driven entrepreneur and founder of Liberty Fox Technologies. 🔹 About This Episode: Bill shares his inspiring journey from an unexpected layoff to creating a successful software consulting company in Philadelphia. Dive into his experiences buil…
  continue reading
 
There is a significant unmet need for medicines to treat neuropsychiatric and neurological conditions in underserved patient populations. Recently, there has been renewed interest in psychedelic, hallucinogenic and dissociative compounds to meet those needs. In clinical trials, a wide array of these compounds are showing efficacy across a variety o…
  continue reading
 
In this episode, we dive into the future of cancer treatment with Dr. Sola Adeleke, founder and CEO of Curenetics. Dr. Adeleke shares how his company is using artificial intelligence (AI) to predict cancer treatment outcomes and improve the personalisation of cancer therapies, particularly in immunotherapy. We explore the key challenges of current …
  continue reading
 
The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. With a presidential election just round the corner in the US and a new UK budget on the way, financial support for life sciences is high on …
  continue reading
 
In the In Conversation With series, a part of the free DDW podcast, DDW speaks with members of the drug discovery industry about their work and how it helps turn science into business. In this episode, Megan Thomas is in conversation with CEO of Oxeia, Dr Michael Wyand, where we talk about Oxeia’s work; the unmet critical need for concussion drug t…
  continue reading
 
世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Déjà Vu In England: Lilly’s Alzheimer’s Drug Kisunla Gets MHRA Yes, But NICE Says No(邦訳:アルツハイマー治療薬ケサンラ承認で議論再び、薬価負担に悩む英国)」URL:  https://insights.citeline.com/pink-sheet/geography/europe/united-kingdom/deja-vu-in-england-lillys-alzheim…
  continue reading
 
Discover how Turbine Simulated Cell Technologies is transforming drug development by addressing biases in training data. Guests Bence Szalai, MD, PhD, and Istvan Taisz, MD, PhD, share insights on the challenges of biased AI models in biology and introduce their groundbreaking framework, EFFECT (Evaluation Framework for Predicting Efficacy of Cancer…
  continue reading
 
We love to hear from our listeners. Send us a message. It might just be coincidence, but it sure seems like Bill Enright has a knack for making big moves at inopportune times, then turning the expected outcome on its ear. For example, he signed on as CEO at Altimmune when the company was struggling mightily. Enright had a turnaround plan in hand, b…
  continue reading
 
Audio roundup of selected biopharma industry content from Scrip over the business week ended 25 October 2024. In this episode: Merck & Co’s Modifi acquisition; scenarios for new obesity drugs; Astellas gets US approval for claudin drug Vyloy; iTeos builds TIGIT lead; and execs discuss AI in clinical trials.https://insights.citeline.com/scrip/quick-…
  continue reading
 
Health technologies are revolutionizing the ways in which life sciences organizations develop and deliver life-saving treatments to patients. In particular, digital therapeutics have become a prominent area of focus due to their potential to improve outcomes while reducing patient burden. Norstella continues to be proponent for these innovative tec…
  continue reading
 
EY recently published their 18th annual Pulse of the MedTech Industry report, highlighting how—despite steadily rising profits year-over-year—devicemakers large and small are still being squeezed by the cost of doing business and waning investor enthusiasm. During AdvaMed’s MedTech Conference this month in Toronto, John Babbitt, partner on the life…
  continue reading
 
In this episode, Francesca Augustine, founder of Neftwork, discusses the intersection of art and blockchain technology, exploring how her platform leverages blockchain to ensure continuous royalties for artists and increase transparency in the art world. She shares insights into how tokenization can revolutionize the art market, providing security,…
  continue reading
 
Loading …

Quick Reference Guide